<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PHH3 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/phh3/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 19 Oct 2026 02:25:02 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>PHH3 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Old-Fashioned Mitotic Count May Outperform Ki67 in Hormone Receptor-Positive Breast Cancer</title>
		<link>https://bioengineer.org/old-fashioned-mitotic-count-may-outperform-ki67-in-hormone-receptor-positive-breast-cancer/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Mon, 19 Oct 2026 02:25:02 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[biomarkers]]></category>
		<category><![CDATA[Breast Cancer]]></category>
		<category><![CDATA[HER2-negative]]></category>
		<category><![CDATA[histologic grade]]></category>
		<category><![CDATA[hormone receptor-positive]]></category>
		<category><![CDATA[Ki67]]></category>
		<category><![CDATA[luminal breast cancer]]></category>
		<category><![CDATA[mitotic count]]></category>
		<category><![CDATA[pathology]]></category>
		<category><![CDATA[PHH3]]></category>
		<category><![CDATA[prognosis]]></category>
		<category><![CDATA[tissue microarray]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=436222</guid>

					<description><![CDATA[A Norwegian population-based study finds that the manual mitotic count retains independent prognostic value in hormone receptor-positive, HER2-negative breast cancer where Ki67 and PHH3 do not, and identifies 2.5 mitoses per square millimeter as equivalent to the standard 20 percent Ki67 cutoff.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">436222</post-id>	</item>
	</channel>
</rss>
